Perrigo Company plc (PIG) - Total Liabilities

Latest as of December 2025: €5.60 Billion EUR ≈ $6.55 Billion USD

Based on the latest financial reports, Perrigo Company plc (PIG) has total liabilities worth €5.60 Billion EUR (≈ $6.55 Billion USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore PIG net assets growth trend to track the company's year-over-year net asset growth rate.

Perrigo Company plc - Total Liabilities Trend (2016–2025)

This chart illustrates how Perrigo Company plc's total liabilities have evolved over time, based on quarterly financial data. See PIG FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Perrigo Company plc Competitors by Total Liabilities

The table below lists competitors of Perrigo Company plc ranked by their total liabilities.

Company Country Total Liabilities
SonoScape Medical Corp
SHE:300633
China CN¥1.04 Billion
Ircon International Limited
NSE:IRCON
India Rs146.36 Billion
Luoyang Longhua Heat Trans Energy
SHE:300263
China CN¥3.92 Billion
Sichuan Jinlu Group Co Ltd
SHE:000510
China CN¥1.54 Billion
Orora Ltd
AU:ORA
Australia AU$1.95 Billion
Weibo Corp
NASDAQ:WB
USA $2.96 Billion
Shenzhen Urban Transport Planning Center Co. Ltd.
SHE:301091
China CN¥975.06 Million
Srisawad Power 1979 PCL
BK:SAWAD
Thailand ฿66.92 Billion

Liability Composition Analysis (2016–2025)

This chart breaks down Perrigo Company plc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Perrigo Company plc (PIG) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.76 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 1.91 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.66 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Perrigo Company plc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Perrigo Company plc (2016–2025)

The table below shows the annual total liabilities of Perrigo Company plc from 2016 to 2025.

Year Total Liabilities Change
2025-12-31 €5.60 Billion
≈ $6.55 Billion
+5.09%
2024-12-31 €5.33 Billion
≈ $6.23 Billion
-11.80%
2023-12-31 €6.04 Billion
≈ $7.06 Billion
-2.17%
2022-12-31 €6.18 Billion
≈ $7.22 Billion
+17.09%
2021-12-31 €5.27 Billion
≈ $6.17 Billion
-9.59%
2020-12-31 €5.83 Billion
≈ $6.82 Billion
+6.11%
2019-12-31 €5.50 Billion
≈ $6.43 Billion
+3.42%
2018-12-31 €5.32 Billion
≈ $6.21 Billion
-2.62%
2017-12-31 €5.46 Billion
≈ $6.38 Billion
-31.02%
2016-12-31 €7.91 Billion
≈ $9.25 Billion
--

About Perrigo Company plc

F:PIG Germany Drug Manufacturers - Specialty & Generic
Market Cap
$1.43 Billion
€1.22 Billion EUR
Market Cap Rank
#7727 Global
#1058 in Germany
Share Price
€8.85
Change (1 day)
-1.21%
52-Week Range
€7.82 - €23.23
All Time High
€125.23
About

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and ora… Read more